Your Location:Home > Products > Solvents > Ferrous lactate
CasNo: 5905-52-2
MF: C6H10FeO6
Appearance: powder
Delivery Time: 15 days
Packing: 25kg/bag
Purity: 99%
Product Details of Ferrous Lactate
1. Basic Information
1.1 Chemical Formula
The chemical formula of ferrous lactate is typically presented as C6H10FeO6⋅3H2O for the trihydrate form, which is a common appearance in the market. This formula indicates the combination of lactate anions (C3H5O3−) with ferrous ions (Fe2+) and three water molecules. The structure reflects the chelation of iron within the lactate complex, which plays a crucial role in its stability and bioavailability.
1.2 Molecular Weight
Calculating based on the formula C6H10FeO6⋅3H2O , the molecular weight of ferrous lactate trihydrate is approximately 288.04 g/mol. This value is derived from the sum of the atomic weights of all the atoms in the formula. The accurate molecular weight is essential for precise dosage calculations in various applications, whether in pharmaceutical formulations or food fortification.
1.3 Physical Properties
Ferrous lactate commonly appears as a greenish - white powder or crystals. The left - handed enantiomer usually exists in the form of a dihydrate, while the racemic mixture is often in the trihydrate form. It has limited solubility in water, with a solubility profile that allows for slow but effective release of iron ions in aqueous environments. It is insoluble in ethanol, which restricts its use in alcohol - based products but makes it suitable for water - based applications such as oral liquid formulations and food fortification in aqueous matrices. The pH of a 1:50 aqueous solution of ferrous lactate ranges between 5 and 6, which is relatively mild and helps to maintain its stability in solution without causing significant pH - related issues in applications.
2. Preparation Specifications
2.1 Tablets
2.2 Capsules
2.3 Oral Liquids
2.4 Syrups
3. Pharmacological Action
Iron is an essential element for the human body. It is a fundamental component of hemoglobin, which is responsible for oxygen transport in red blood cells. Hemoglobin binds to oxygen in the lungs and releases it to tissues throughout the body. Iron is also a key component of myoglobin, which stores oxygen in muscle cells, and is involved in the function of various enzymes, such as cytochromes in the electron transport chain, which are crucial for energy production.
Ferrous lactate has a relatively high absorption rate compared to some other iron supplements. In the acidic environment of the stomach, ferrous lactate dissociates into ferrous ions (Fe2+) and lactate ions (C3H5O3−). The ferrous ions are then absorbed through the intestinal mucosa, mainly in the duodenum and upper jejunum. The presence of lactate may enhance iron absorption by forming a soluble complex with iron, protecting it from oxidation to the less - absorbable ferric form (
Fe3+
) and facilitating its transport across the intestinal epithelium.
4. Indications
The primary indication for ferrous lactate is the treatment of iron - deficiency anemia. Iron - deficiency anemia occurs when the body does not have enough iron to produce an adequate amount of hemoglobin. This can be due to various factors, such as poor dietary intake of iron - rich foods, increased iron requirements (e.g., during pregnancy, lactation, or rapid growth in children), chronic blood loss (e.g., from menstruation, gastrointestinal bleeding), or malabsorption disorders.
Symptoms of iron - deficiency anemia include fatigue, weakness, pallor (pale skin), shortness of breath, dizziness, and poor concentration. By supplementing with ferrous lactate, the body can increase its iron stores, allowing for the production of sufficient hemoglobin and alleviating the symptoms of anemia.
5. Application Areas
5.1 Food Industry
5.2 Pharmaceutical Industry
6. Adverse Reactions
6.1 Gastrointestinal Discomfort
Common gastrointestinal adverse reactions associated with ferrous lactate include nausea, vomiting, and upper abdominal pain. These symptoms occur because iron can irritate the lining of the stomach and intestines. Nausea and vomiting may be more pronounced in individuals who are sensitive to iron or when the supplement is taken on an empty stomach. The iron can also cause constipation by reducing intestinal motility. Additionally, the iron in ferrous lactate is not fully absorbed by the body, and the unabsorbed iron is oxidized in the intestine, resulting in black - colored stools. This change in stool color can be alarming to patients but is a normal side - effect of iron supplementation.
6.2 Allergic Reactions
Although rare, some individuals may be allergic to ferrous lactate or other components in the formulation. Allergic reactions can range from mild symptoms such as skin rashes, itching, and hives to more severe reactions like swelling of the face, lips, tongue, or throat, difficulty breathing, and anaphylaxis. If a patient experiences any of these symptoms after taking ferrous lactate, they should seek immediate medical attention.
7. Contraindications
7.1 Severe Liver and Kidney Dysfunction
Patients with severe liver and kidney impairment, especially those with untreated urinary tract infections, should not use ferrous lactate. The liver and kidneys play important roles in the metabolism and excretion of iron. In patients with liver or kidney disease, the normal regulation of iron metabolism may be disrupted, leading to iron overload. Additionally, in the case of urinary tract infections, the presence of iron in the body can potentially promote the growth of bacteria, worsening the infection.
7.2 Iron Overload Conditions
Individuals with iron - overload conditions such as hemochromatosis or hemosiderosis should avoid ferrous lactate. Hemochromatosis is a genetic disorder that causes the body to absorb too much iron from the diet, leading to iron accumulation in various organs, which can cause damage to the liver, heart, pancreas, and other organs. Hemosiderosis is a condition characterized by the abnormal deposition of iron - containing pigment (hemosiderin) in tissues. In both cases, further iron supplementation can exacerbate the iron - overload situation and worsen the associated health problems.
7.3 Non - Iron - Deficiency Anemias
Patients with non - iron - deficiency anemias, such as thalassemia, should not use ferrous lactate. Thalassemia is a group of genetic blood disorders characterized by abnormal hemoglobin production. In thalassemia, the problem is not related to iron deficiency, and iron supplementation can be harmful as it can lead to iron overload in the body.
8. Storage Method
Ferrous lactate should be stored in a cool, dark place, with the temperature not exceeding 20℃. It should be kept in a tightly sealed container to protect it from light, moisture, and air. Exposure to light can cause oxidation of the ferrous ions to ferric ions, reducing the effectiveness of the product. Moisture can also lead to the degradation of ferrous lactate, affecting its stability and solubility. By storing it properly, the shelf - life of ferrous lactate products can be extended, ensuring that they remain effective for the recommended period.
9. Shelf - Life
Under proper storage conditions, ferrous lactate products typically have a shelf - life of 24 months. However, this may vary depending on the specific formulation and packaging. For example, products in air - tight, light - resistant packaging may have a longer shelf - life compared to those in less protective packaging. It is important to check the expiration date on the product label before use to ensure its quality and effectiveness.
10. Execution Standards